Form 4: Cargo Therapeutics Executive Sells Shares to Cover Tax Obligations

Anup Radhakrishnan, Interim CEO, CFO, and COO of Cargo Therapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 14, 2025, Anup Radhakrishnan, Interim Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer of Cargo Therapeutics, Inc., sold 27,404 shares of common stock.
• The sale was executed at a weighted average price of $3.8415 per share, with individual trades ranging from $3.8400 to $3.8957.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Radhakrishnan directly owns 122,413 shares of Cargo Therapeutics common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports a routine transaction (stock sale for tax obligations) by an executive, which doesn't inherently indicate positive or negative news about the company's performance.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors. The sale appears to be related to tax obligations, which is a typical reason for insider sales.

Key Dates

Keywords

Cargo Therapeutics, CRGX, Anup Radhakrishnan, stock sale, Form 4, insider trading, tax withholding, restricted stock units